In the last trading session, 1.53 million shares of the Voyager Therapeutics Inc. (NASDAQ:VYGR) were traded, and its beta was 1.02. Most recently the company’s share price was $12.37, and it changed around -$1.48 or -10.69% from the last close, which brings the market valuation of the company to $501.73M. VYGR currently trades at a discount to its 52-week high of $14.34, offering almost -15.93% off that amount. The share price’s 52-week low was $4.61, which indicates that the current value has risen by an impressive 62.73% since then. We note from Voyager Therapeutics Inc.’s average daily trading volume that its 10-day average is 0.82 million shares, with the 3-month average coming to 422.95K.
Voyager Therapeutics Inc. stock received a consensus recommendation rating of an Overweight, based on a mean score of 1.90. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended VYGR as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Voyager Therapeutics Inc. is expected to report earnings per share of -$0.57 for the current quarter.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Voyager Therapeutics Inc. (NASDAQ:VYGR) trade information
Instantly VYGR has showed a red trend with a performance of -10.69% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 14.34 on Tuesday, 05/23/23 increased the stock’s daily price by 13.74%. The company’s shares are currently up 102.79% year-to-date, but still up 8.84% over the last five days. On the other hand, Voyager Therapeutics Inc. (NASDAQ:VYGR) is 60.65% up in the 30-day period. We can see from the shorts that 1.02 million shares have been sold at a short interest cover period of 4.35 day(s).
The consensus price target as assigned by Wall Street analysts is $13.67, which translates to bulls needing to increase their stock price by 9.51% from its current value. Analyst projections state that VYGR is forecast to be at a low of $9.00 and a high of $18.00. In order for the stock price to hit the forecast high, the stock would need to plunge -45.51% from its current level, while the stock would need to crash 27.24% from its current level to reach the projected low.
Voyager Therapeutics Inc. (VYGR) estimates and forecasts
Voyager Therapeutics Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 129.07 percent over the past six months and at a 183.47% annual growth rate that is well above the industry average of 11.20%. Moreover, analysts have decided to roll up on their fiscal year 2023 revenue estimates. The rating firms predict that it will loss -14.00% in revenue this quarter, and will report a decrease of -231.10% in the next quarter. The year-over-year growth rate is expected to be 282.90%, up from the previous year.
Consensus estimates provided by 7 financial analysts predict the company will bring in an average of $1.6 million in revenue for the current quarter. 7 analysts expect Voyager Therapeutics Inc. to make $1.56 million in revenue for the quarter ending Sep 2023. The company’s sales for the same quarters a year ago were $712k and $9.42 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 124.70%. Forecasts for the next quarter put sales growth at -83.40%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 14.40%.
Voyager Therapeutics Inc.’s next quarterly earnings report is expected to be released in June.
Voyager Therapeutics Inc. (NASDAQ:VYGR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 23.75% of Voyager Therapeutics Inc. shares, and 46.84% of them are in the hands of institutional investors. The stock currently has a share float of 61.43%. Voyager Therapeutics Inc. stock is held by 97 institutions, with EcoR1 Capital, LLC being the largest institutional investor. By Mar 30, 2023, it held 8.85% of the shares, which is about 3.85 million shares worth $29.7 million.
Armistice Capital, LLC, with 8.09% or 3.52 million shares worth $27.17 million as of Mar 30, 2023, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Explorer Fund, Inc. were the top two Mutual Funds as of Dec 30, 2022. The former held 0.97 million shares worth $5.89 million, making up 2.23% of all outstanding shares. On the other hand, Vanguard Explorer Fund, Inc. held roughly 0.46 million shares worth around $4.31 million, which represents about 1.06% of the total shares outstanding.